Predictors of Complications and CKD Progression in Adult Nephrotic Syndrome: A Cohort Study
Journal of Clinical Nephrology · 13.03.2026 · 032-038
DOI: 10.29328/journal.jcn.1001173 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Nephrology, online erschienen am 13.03.2026. Verfasst von Firdaous Boumaiz und 5 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aims: Nephrotic syndrome (NS) is a glomerular syndrome characterized by massive proteinuria and severe complications, including chronic kidney disease (CKD). This study aimed to describe the demographic, clinical, biochemical, histological, and etiological characteristics of patients with NS, to identify risk factors for complications, and to assess predictors of progression to CKD in a Moroccan setting.Methods: This retrospective, descriptive, and analytical study was conducted in the Nephrology Department of CHU Ibn Sina, Rabat, Morocco, from 2019 to 2024. It included 308 patients hospitalized for NS, aged >15 years, with proteinuria ≥3.5 g/day and hypoalbuminemia
Zitieren
APA
Boumaiz, F., Zniber, A., Sakout, N., Kadiri, N., Ouzeddoun, N., & Benamar, L. (2026). Predictors of Complications and CKD Progression in Adult Nephrotic Syndrome: A Cohort Study. Journal of Clinical Nephrology, 032-038. https://doi.org/10.29328/journal.jcn.1001173
Vancouver
Boumaiz F, Zniber A, Sakout N, Kadiri N, Ouzeddoun N, Benamar L. Predictors of Complications and CKD Progression in Adult Nephrotic Syndrome: A Cohort Study. Journal of Clinical Nephrology. 2026:032-038. doi:10.29328/journal.jcn.1001173
BibTeX
@article{Boumaiz2026,
author = {Boumaiz, Firdaous and Zniber, Amal and Sakout, Nadia and Kadiri, Nada and Ouzeddoun, Naima and Benamar, Loubna},
title = {Predictors of Complications and CKD Progression in Adult Nephrotic Syndrome: A Cohort Study},
journal = {Journal of Clinical Nephrology},
year = {2026},
pages = {032--038},
doi = {10.29328/journal.jcn.1001173}
}
EUVIMED